ProCE Banner Events

Share

APPlexus Hematology: Clinic-Ready Insights from the Top Abstracts Presented at the 2023 Annual Hematology Meeting

APPlexus Hematology is an initiative designed to address educational needs specific to APPs who care for patients with malignant or nonmalignant hematologic disorders. These webinars will navigate the profound insights from the 2023 ASH Annual Meeting (#ASH23) and will deliver innovative, real-time education to NPs and PAs worldwide. Our mission is to bridge knowledge gaps, untangle controversies, and spotlight pivotal abstracts from #ASH23 in a digestible and engaging format.

Nurse Practitioners: 3.00 Nursing contact hours, includes 3.00 hour of pharmacotherapy credit

Physician Assistants/Physician Associates: 3.00 AAPA Category 1 CME credits

This event has expired. No longer available for credits.

Who Should Attend

This program is intended for NPs, PAs, and other healthcare professionals who care for patients with malignant or nonmalignant hematologic disorders.

Time and location

Saturday, February 03, 2024

8:00 AM - 1:20 PM Eastern Time (ET)

Virtual

Faculty
Cyrus Khan, MD

Director of Marrow Collection Facility Cell Transplant Program
Hematology Oncology
Western Pennsylvania Hospital
Pittsburgh, Pennsylvania

Christopher Nelson, MSN, ACNP-BC, MBA

Acute Care Nurse Practitioner
Oncology Avera Cancer Institute
Sioux Falls, SD

Amy Goodrich, MSN-CRNP-AC

Nurse Practitioner
Johns Hopkins School of Medicine
Johns Hopkins Kimmel Cancer Center
Baltimore, Maryland

Lisa Nodzon, PhD, APRN, AOCNP

Moffitt Cancer Center
Department of Malignant Hematology
Tampa, Florida

Eunice S. Wang, MD

Chief, Leukemia and Benign Hematology Service
Professor of Oncology
Roswell Park Comprehensive Cancer Center
Buffalo, New York

Beth Faiman, PhD, MSN, APN-BC, AOCN, BMTCN, FAAN, FAPO

Cleveland Clinic Taussig Cancer Institute
Department of Hematology and Medical Oncology
Member, Population and Cancer Prevention Program
Case Comprehensive Cancer Center 9500 Euclid Avenue CA-6
Cleveland, Ohio

Agenda

Session Time (ET)         Topic
8:00 AM – 8:05 AM         Welcome
8:05 AM – 8:50 AM         Leukemias - Insights from ASH 2023
8:50 AM – 9:05 AM         Session Q&A
9:05 AM – 9:10 AM         Break
9:10 AM – 10:10 AM         Nonaccredited Presentation Theater: Long-Term Clinical Trial Results for a BTKi in the Treatment of CLL/SLL Sponsored by AstraZeneca 
10:10 AM – 10:55 AM         Lymphoma I (CLL and MCL) - Insights from ASH 2023
10:55 AM – 11:10 AM         Session Q&A
11:10 AM – 11:15 AM         Break
11:15 AM – 12:15 PM         Nonaccredited Presentation Theater: Polycythemia Vera Clinical Case Discussion: When to Intervene With Jakafi® (ruxolitinib) Sponsored by Incyte Corporation 
12:15 PM – 1:00 PM         Lymphoma II (DLBCL, FL, cHL, and PTCL) - Insights from ASH 2023
1:00 PM – 1:15 PM         Session Q&A
1:15 PM – 1:20 PM         Closing Remarks

CME/CE Info

Goal Statement
To improve the knowledge, confidence, and skills of NPs/PAs who care for patients with malignant or nonmalignant hematologic disorders regarding the latest updates in guideline-directed evidence-based medicine, therapeutic management, and strategies to improve health equity, ultimately improving clinical outcomes for their patients. 

Target Audience
This program is intended for NPs, PAs, and other healthcare professionals who care for patients with malignant or nonmalignant hematologic disorders. 

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Integrate recent clinical data to tailor and enhance treatment strategies for patients diagnosed with malignant or nonmalignant hematologic conditions.
  • Assess the implications and potential of emerging agents and therapeutic innovations in managing patients with malignant or nonmalignant hematologic disorders.
  • Evaluate the potential impact of contemporary trial outcomes on shaping future treatment paradigms for patients with malignant or nonmalignant hematologic disorders.

Accreditation

Joint Accreditation Statement

In support of improving patient care, Partners for Advancing Clinical Education (PACE) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. 

Nursing Continuing Professional Development
The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 3.0 contact hours, including 3.0 hours of pharmacology credit.

- Leukemias - 1.0
- Lymphomas I - 1.0
- Lymphomas II - 1.0

Physician Associate Continuing Medical Education

Partners for Advancing Clinical Education (PACE) has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 3.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

- Leukemias - 1.0
- Lymphomas I - 1.0
- Lymphomas II - 1.0

IPCE Credit Designation



This activity was planned by and for the healthcare team, and learners will receive 3.0 Interprofessional Continuing Education (IPCE) credits for learning and change.

- Leukemias - 1.0
- Lymphomas I - 1.0
- Lymphomas II - 1.0

Disclosure of Conflicts of Interest 
PACE requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships are mitigated according to PACE policies.

Acknowledgement

Provided by Partners for Advancing Clinical Education (PACE) in partnership with Practicing Clinicians Exchange, LLC and Clinical Care Options, LLC

Supported by an educational grant from AbbVie Inc.

Contact Information

For customer support please click here.

Mailing Address:

 

Practicing Clinicians Exchange
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Additional Information

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact customer support prior to the live event.